← All Companies
Shuttle Pharmaceuticals Holdings, Inc.
SHPH · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary PART I On November 21, 2025, we acquired substantially all of the assets and liabilities of Molecule.ai, a pharmaceutical software company building an artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. By combining modern AI techniques with structured scientific workflows, the Molecule.ai platform (hereafter, Molecule.ai or the platform) helps researchers explore the chemical space more efficiently, evaluate molecular ideas with greater clarity...
Next Earnings Q2 FY2026 — expected 2026-09-16
Key Facts from Earnings Calls Type Subject Detail Quarter topic_mention SHPH discussed_in_filing Artificial Intelligence topic_mention SHPH discussed_in_filing Cybersecurity topic_mention SHPH discussed_in_filing Trusted Computing topic_mention SHPH discussed_in_filing Blockchain & Crypto topic_mention SHPH discussed_in_filing Autonomous Vehicles topic_mention SHPH discussed_in_filing Regulation topic_mention SHPH discussed_in_filing Healthcare & Bio topic_mention SHPH discussed_in_filing AI Compute topic_mention SHPH discussed_in_filing Platform & Ecosystem topic_mention SHPH discussed_in_filing Artificial Intelligence topic_mention SHPH discussed_in_filing Cybersecurity topic_mention SHPH discussed_in_filing Trusted Computing topic_mention SHPH discussed_in_filing Blockchain & Crypto topic_mention SHPH discussed_in_filing Autonomous Vehicles topic_mention SHPH discussed_in_filing Regulation topic_mention SHPH discussed_in_filing Healthcare & Bio topic_mention SHPH discussed_in_filing AI Compute topic_mention SHPH discussed_in_filing Platform & Ecosystem topic_mention SHPH discussed_in_filing Artificial Intelligence topic_mention SHPH discussed_in_filing Cybersecurity
Annual Reports (10-K) Filed Period Accession Source Full Text 2026-03-31 2025-12-31 0001493152-26-014131 EDGAR 45K words 2025-02-26 2024-12-31 0001493152-25-008300 EDGAR — 2024-03-21 2023-12-31 0001493152-24-010822 EDGAR — 2023-03-15 2022-12-31 0001493152-23-007686 EDGAR —
Quarterly Reports (10-Q) Filed Period Accession Source Full Text 2025-11-13 2025-09-30 0001493152-25-022162 EDGAR 26K words 2025-08-13 2025-06-30 0001641172-25-023263 EDGAR — 2025-05-08 2025-03-31 0001641172-25-009325 EDGAR — 2024-11-13 2024-09-30 0001493152-24-045176 EDGAR — 2024-09-04 2024-06-30 0001493152-24-034902 EDGAR — 2024-05-13 2024-03-31 0001493152-24-018944 EDGAR — 2023-11-13 2023-09-30 0001493152-23-040531 EDGAR — 2023-08-14 2023-06-30 0001493152-23-028462 EDGAR — 2023-05-25 2023-03-31 0001493152-23-019138 EDGAR — 2022-11-14 2022-09-30 0001493152-22-032276 EDGAR —
Recent Current Reports (8-K) Filed Accession Source Full Text 2026-03-10 0001493152-26-009551 EDGAR 19K words 2026-02-17 0001493152-26-007204 EDGAR — 2026-02-02 0001493152-26-004782 EDGAR — 2026-01-12 0001493152-26-001861 EDGAR — 2025-12-29 0001493152-25-029361 EDGAR — 2025-11-28 0001493152-25-025430 EDGAR — 2025-11-26 0001493152-25-025082 EDGAR — 2025-11-21 0001493152-25-024618 EDGAR — 2025-11-17 0001493152-25-023845 EDGAR — 2025-11-07 0001493152-25-021256 EDGAR —
130 total filings indexed. 106 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers Company Identity
CIK 0001757499
Ticker SHPH
Exchange Nasdaq
SIC 2834: Pharmaceutical Preparations
Incorporated DE
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 141f9a3b2b359bbd3914e67da45219ee3dbbeeb43c9d28eb965fcfa5112ebb2d
parent: 897d13c4828d88b4b6720b874e00f89233f7af65cdcdbcf914703274410f0b62
content hash: b652f8f353a6d3c267205e77cb03f4ce1d5841661640d65a02573bd4ba57187c
signed: 2026-04-13T04:47:25.983Z
sources: 14 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf